Saint Luke's Foundation
Total Page：16
File Type：pdf, Size：1020Kb
SAINT LUKE’S REPOAN UPDATE FROM SAINT LUKE’S HOSPITAL FOUNDATIONR • 2010 T 2009 Saint Luke’s Hospital Foundation Annual Report Growing Strong From a new women’s center to clinical research, Saint Luke’s is enhancing care for Kansas City area patients and beyond 1 Vaccine therapy takes aim Growing Strong at brain tumors From new women’s facilities to clinical research, Saint Luke’s Saint Luke’s Brain Tumor Center began is enhancing care for Kansas City area patients and beyond studying an exciting new vaccine treatment for brain tumors in April 2010. This novel therapy utilizes a patient’s own tumor cells to create a personalized A Woman’s Place vaccine to generate an immune response against the cancer. This treatment is In April 2010, Saint Luke’s Hospital aimed at patients with recurrent high-grade unveiled its new women’s centers that cater gliomas, a fast-growing type of brain tumor specifically to female patients. The facili- that tends to return despite treatment. ties are part of Saint Luke’s $330 million Partnering with TVAX Biomedical, a expansion project. local biotech company, Saint Luke’s is the From cutting-edge heart and breast only site in the country testing this new care to high-risk maternity services approach for brain tumors. and preventive screenings, Saint Luke’s Saint Luke’s Brain Tumor Center is has women’s best interests in mind. A led by Michael Salacz, M.D., the only dedicated entrance, circle drive with covered fellowship-trained neuro-oncologist in the drop-off, and free valet parking give patients region, and is the only dedicated clinic for easy access to the services inside. patients with brain and spinal cord tumors. The facility houses two adjoining programs, the Ellen Hockaday Center for Women’s Care and the Muriel I. Kauffman Women’s Heart Center. Both were made square feet, the unit is nearly double the possible with charitable gifts including do- size of the former space. nations from the Irv and Ellen Hockaday The unit is steps from the hospital’s family and Julia Irene Kauffman. Level IIIb Neonatal Intensive Care Unit Where moms are babied (NICU), the state’s highest designation In September, the hospital opened for care. Board-certified neonatologists Michael Salacz, M.D., Brain Tumor Center Medical Director spacious, well-appointed new birthing staff the NICU 24/7, ensuring the best suites. care possible for standard and high-risk Located on the second floor of the El- pregnancies. Super glue for aneurysms The unit is also in close proximity to the len Hockaday Center for Women’s Care, Patients who develop brain aneurysms new Women’s Shoppe, a source for post- the unit offers women and their families can suffer a stroke or die if the aneurysm partum, breastfeeding and other supplies. an inviting, comfortable and technically breaks open and bleeds. An aneurysm advanced setting aimed at providing an Saint Luke’s Hospital delivers more occurs when a blood vessel in the brain exceptional birth experience. At 23,300 than 2,200 babies each year. bulges. When the opening, or neck, from the bulge to the vessel is large, it’s called a wide-necked aneurysm. Before now, few treatment options existed for this type. However, Saint Luke’s William Holloway, M.D., offers a 2 new liquid treatment for wide-necked Because it delivers a very precise, highly Saint Luke’s Cancer Institute aver- brain aneurysms. targeted dose of radiation, treatment with ages seven to eight active clinical trials for The neurointerventional radiologist at SAVI can be completed in just five days, radiation oncology at any given time and Saint Luke’s Brain and Stroke Institute is where traditional external beam radiation is recognized nationwide as a high-accrual among the few doctors in the country and takes several weeks. center of excellence for clinical trials. the only one locally using Onyx® HD 500. The new FDA-approved treatment planted as a cuff around the ascending literally blocks the blood flow to the aneu- 25 years of heart aorta. It inflates and deflates, providing rysm, reducing the pressure and likelihood transplants counter pulsation and increasing blood of rupture. It consists of a glue-like sub- flow to the heart. It represents an stance that solidifies almost immediately In 2010 Saint Luke’s Mid America important advancement because it can when it’s injected via a micro-catheter into Heart and Vascular Institute celebrated the be implanted with a minimally invasive the aneurysm. With the blood blocked, the 25th year of its heart transplant program. It surgical procedure and does not require aneurysm cannot rupture or grow. is the only such program in the Kansas City the use of blood-thinning medications. area. Saint Luke’s has performed more On-target cancer treatment than 483 transplants since 1985. It ranks Heart valve study: ninth in the nation for number of adult The results are in Saint Luke’s Cancer Institute is one transplants, surpassing benchmarks for of the only centers in the Kansas City volumes and survival. Those with faulty heart valves who area offering Stereotactic Body Radiation are considered high risk for surgery Therapy, or SBRT, for treatment of lung have hope thanks to a treatment at and liver tumors or tumors near the Saint Luke’s Mid America Heart and spinal cord. Using special software, it Vascular Institute. directs a highly targeted beam of high- Saint Luke’s is the only hospital dose radiation at the tumor. The higher in the region—and one of only 17 in dose and precise targeting allow the the country—that participated in the patient to complete treatment in one PARTNER clinical trial. It evaluated Michael Borkon, M.D. week versus the five to seven weeks of placement of transcatheter aortic heart Cardiac Transplant Surgical Director daily treatment needed with traditional valves in patients with severe aortic therapy. It is performed on an outpatient Saint Luke’s Heart Failure and stenosis (a narrowing that restricts basis and most patients continue to work Transplant Program is an integrated blood flow) who were not candidates or carry on their normal daily activities program offering comprehensive services for traditional replacement surgery. during treatment. to patients with all stages of heart failure, Doctors use a catheter to open the Breast cancer patients who require including mechanical circulatory support diseased valve and position the me- partial breast irradiation following a and heart transplantation. Patients chanical valve. Because the procedure lumpectomy also have a new treatment have access to a wide array of research is minimally invasive, it avoids many option. SAVITM is a 10-channel balloon medications and devices to enhance their of the complications of traditional catheter that is placed in the lumpectomy functional capacity. Such devices can delay open heart valve surgery. Study cavity to deliver targeted radiation. Similar the need for a transplant or provide long- patients who received the valve had a 54 to MammoSite®, a one-channel device, term therapy. percent lower risk of death or hospi- it allows for more complex dosing and Clinical studies of ventricular assist talization from heart failure compared targeting. This is good news for lumpectomy devices for end-stage heart failure are to those receiving standard medical patients with tumor cavities that don’t allow ongoing. In 2010, Saint Luke’s became therapy alone. Results appeared in the MammoSite therapy due to their proximity the only center in the region to test the Sept. 23, 2010, New England Journal of to the rib cage or other organs in the body. C-pulse heart assist device, which is im- Medicine. $6.6 million 9 51 Amount provided by Saint Luke’s Number of endowed chairs supported Number of active clinical trials at Saint Hospital Foundation in 2009 for by $1,016,000 from Foundation funds in Luke’s Mid America Heart and Vascular medical research, including heart, 2009. These positions foster academic Institute that enrolled more than 2,000 cancer, neuroscience, diabetes, surgery, inquiry through their contributions to patients in 2009, thanks to support gastroenterology, and other areas. medical education and research. from donors and private industry. 3 HOSPITAL KEY FINANCIAL RESULTS 2009 HOSPITAL PATIENT CARE REVENUE SOURCES 2009 SOURCES Teaching and indigent care (including Medicaid) 14.0% Non-operating revenue $ 66,169,000 Medicare 39.4 Total operating revenue 442,680,000 (net of charity, teaching deductions, Private insurance/managed care 46.6 and contractual allowances) Total $ 508,849,000 HOSPITAL EXPENSES 2009 USES Utilities 1.1% $ 4,766,000 Facility costs $ 35,653,000 Property costs 4.0 17,710,000 Debt retirement and additions to reserves 66,625,000 Personnel costs 221,429,000 Other expenses 8.1 35,834,000 Medical and other expenses 185,142,000 Outside services 18.3 81,004,000 Total $ 508,849,000 Supplies 18.4 81,481,000 Salaries and benefits 50.1 221,429,000 HOSPITAL KEY VOLUME STATISTICS 2009 Hospital admissions, including newborns 18,314 Total $ 442,224,000 Census days of care including newborns 92,237 Emergency department visits 34,496 FOUNDATION REVENUE SOURCES 2009 Open heart surgeries and angioplasties 2,201 Net realized and unrealized gains on investments $ 15,831,594 Surgical cases 9,516 Investment income 2,402,622 Outpatient registrations 118,971 Other sources of income, including rent income 7,776,278 Gifts, grants, and bequests 11,639,784 Total $ 37,650,278 FOUNDATION HOLDINGS 2009 FOUNDATION GIFTS AND GRANTS: TRANSFERS TO HOSPITAL $24,000,000,00 + + $22,000,000.00 F A $20,000,000.00 $1 8,000,000.00 E B + + $1 6,000,000.00 D $1 4,000,000.00 $1 2,000,000.00 + C $1 0,000,000.00 + + + + $ 8,000,000.00 + + $ 6,000,000.00 A Bonds .